| Product Code: ETC6739238 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Central Nervous System Therapeutic Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Central Nervous System Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 China Central Nervous System Therapeutic Market - Industry Life Cycle |
3.4 China Central Nervous System Therapeutic Market - Porter's Five Forces |
3.5 China Central Nervous System Therapeutic Market Revenues & Volume Share, By Disease, 2021 & 2031F |
4 China Central Nervous System Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in China |
4.2.2 Growing awareness about mental health and neurological conditions |
4.2.3 Government initiatives to improve healthcare infrastructure in China |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for CNS therapeutics in China |
4.3.2 High cost of research and development for CNS drugs |
4.3.3 Limited access to advanced CNS therapies in remote areas of China |
5 China Central Nervous System Therapeutic Market Trends |
6 China Central Nervous System Therapeutic Market, By Types |
6.1 China Central Nervous System Therapeutic Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 China Central Nervous System Therapeutic Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 China Central Nervous System Therapeutic Market Revenues & Volume, By Neurovascular Diseases, 2021- 2031F |
6.1.4 China Central Nervous System Therapeutic Market Revenues & Volume, By CNS Trauma, 2021- 2031F |
6.1.5 China Central Nervous System Therapeutic Market Revenues & Volume, By Mental Health, 2021- 2031F |
6.1.6 China Central Nervous System Therapeutic Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.1.7 China Central Nervous System Therapeutic Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.1.8 China Central Nervous System Therapeutic Market Revenues & Volume, By CNS Cancer, 2021- 2031F |
7 China Central Nervous System Therapeutic Market Import-Export Trade Statistics |
7.1 China Central Nervous System Therapeutic Market Export to Major Countries |
7.2 China Central Nervous System Therapeutic Market Imports from Major Countries |
8 China Central Nervous System Therapeutic Market Key Performance Indicators |
8.1 Number of clinical trials for CNS therapeutics conducted in China |
8.2 Adoption rate of novel CNS therapies in urban vs rural areas |
8.3 Investment in CNS research and development by pharmaceutical companies in China |
9 China Central Nervous System Therapeutic Market - Opportunity Assessment |
9.1 China Central Nervous System Therapeutic Market Opportunity Assessment, By Disease, 2021 & 2031F |
10 China Central Nervous System Therapeutic Market - Competitive Landscape |
10.1 China Central Nervous System Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 China Central Nervous System Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here